Key Takeaways:
Metis Techbio-P (07666.HK) has kicked off its Initial Public Offering (IPO) on the Hong Kong Stock Exchange, seeking to raise HKD2.11 billion.
The biotechnology firm's public share sale will run until May 8, according to the official announcement.
Metis Techbio-P is offering 201 million H-shares at a price of HKD10.5 per share. Of the total shares, 5 percent are allocated for the Hong Kong public offering. For retail investors, the entry cost for a board lot of 500 shares is approximately HKD5,303.
The company's shares are scheduled to be listed and commence trading on the Main Board of the Hong Kong Stock Exchange on May 13. The pricing gives the company a significant valuation as it enters the public market. First-day trading on May 13 will be a key test of institutional and retail investor demand for the biotech firm.
This article is for informational purposes only and does not constitute investment advice.
